Exposé of misleading claims that male circumcision will increase HIV infections in Africa.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 28299069)

Published in J Public Health Africa on September 05, 2011

Authors

Brian J Morris1, Jake H Waskett2, Ronald H Gray3, Daniel T Halperin4, Richard Wamai5, Bertran Auvert6, Jeffrey D Klausner7

Author Affiliations

1: School of Medical Sciences, University of Sydney, Sydney, Australia.
2: Circumcision Independent Reference and Commentary Service, Radcliffe, Manchester, UK.
3: Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
4: Department of Global Health and Population, Harvard School of Public Health, Boston, MA, USA.
5: Department of African-American Studies, Northeastern University, Boston, MA, USA.
6: INSERM-UVSQ U1018, Villejuif, France.
7: Divisions of AIDS & Infectious Diseases, University of California, San Francisco, CA, USA.

Articles cited by this

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71

THE ENVIRONMENT AND DISEASE: ASSOCIATION OR CAUSATION? Proc R Soc Med (1965) 40.52

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69

The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis (2011) 16.88

Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS (2000) 8.94

Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med (2009) 8.26

Circumcision in HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomised controlled trial. Lancet (2009) 6.80

Male circumcision and HIV infection: 10 years and counting. Lancet (1999) 6.63

The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53

Circumcision in the United States. Prevalence, prophylactic effects, and sexual practice. JAMA (1997) 6.21

The case for boosting infant male circumcision in the face of rising heterosexual transmission of HIV. Med J Aust (2010) 5.94

Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep (2007) 5.32

Human immunodeficiency virus (HIV) risk, prevention, and testing behaviors--United States, National HIV Behavioral Surveillance System: men who have sex with men, November 2003-April 2005. MMWR Surveill Summ (2006) 5.15

Male circumcision and risk of syphilis, chancroid, and genital herpes: a systematic review and meta-analysis. Sex Transm Infect (2006) 5.11

Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2009) 4.86

Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in Orange Farm, South Africa. J Infect Dis (2009) 4.63

Fine-touch pressure thresholds in the adult penis. BJU Int (2007) 4.46

Langerin is a natural barrier to HIV-1 transmission by Langerhans cells. Nat Med (2007) 4.20

Male circumcision for HIV prevention: from evidence to action? AIDS (2008) 4.11

The effect of male circumcision on sexual satisfaction and function, results from a randomized trial of male circumcision for human immunodeficiency virus prevention, Rakai, Uganda. BJU Int (2008) 3.73

Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine (2006) 3.72

Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol (2002) 3.66

Circumcision and HIV infection: review of the literature and meta-analysis. Int J STD AIDS (1999) 2.95

The emergence of HIV/AIDS in the Americas and beyond. Proc Natl Acad Sci U S A (2007) 2.89

Prevalence of circumcision and herpes simplex virus type 2 infection in men in the United States: the National Health and Nutrition Examination Survey (NHANES), 1999-2004. Sex Transm Dis (2007) 2.86

Potential HIV-1 target cells in the human penis. AIDS (2006) 2.84

Condom promotion for AIDS prevention in the developing world: is it working? Stud Fam Plann (2004) 2.60

Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57

Risk compensation is not associated with male circumcision in Kisumu, Kenya: a multi-faceted assessment of men enrolled in a randomized controlled trial. PLoS One (2008) 2.43

Male circumcision for prevention of heterosexual acquisition of HIV in men. Cochrane Database Syst Rev (2003) 2.32

Effect of HSV-2 serostatus on acquisition of HIV by young men: results of a longitudinal study in Orange Farm, South Africa. J Infect Dis (2009) 2.23

Adult male circumcision: effects on sexual function and sexual satisfaction in Kisumu, Kenya. J Sex Med (2008) 2.23

Human papillomavirus and circumcision: a meta-analysis. J Infect (2006) 2.17

The effects of circumcision on the penis microbiome. PLoS One (2010) 2.15

Male circumcision, religion, and infectious diseases: an ecologic analysis of 118 developing countries. BMC Infect Dis (2006) 2.10

Foreskin surface area and HIV acquisition in Rakai, Uganda (size matters). AIDS (2009) 2.01

Incidence of meatal stenosis following neonatal circumcision in a primary care setting. Clin Pediatr (Phila) (2006) 2.00

Why circumcision is a biomedical imperative for the 21(st) century. Bioessays (2007) 1.88

Keratinization of the adult male foreskin and implications for male circumcision. AIDS (2010) 1.85

Cost-effectiveness of newborn circumcision in reducing lifetime HIV risk among U.S. males. PLoS One (2010) 1.77

Fine-touch pressure thresholds in the adult penis. BJU Int (2007) 1.66

The Strong Protective Effect of Circumcision against Cancer of the Penis. Adv Urol (2011) 1.63

A community trial of the impact of improved sexually transmitted disease treatment on the HIV epidemic in rural Tanzania: 2. Baseline survey results. AIDS (1995) 1.60

Condom use and HIV risk behaviors among U.S. adults: data from a national survey. Fam Plann Perspect (1999) 1.57

HIV incidence in 3 years of follow-up of a Zimbabwe cohort--1998-2000 to 2001-03: contributions of proximate and underlying determinants to transmission. Int J Epidemiol (2008) 1.54

Neonatal circumcision: associated factors and length of hospital stay. J Fam Pract (1995) 1.53

Private sexual behavior, public opinion, and public health policy related to sexually transmitted diseases: a US-British comparison. Am J Public Health (1998) 1.49

A critique of international indicators of sexual risk behaviour. Sex Transm Infect (2004) 1.42

Association between HIV and subpreputial penile wetness in uncircumcised men in South Africa. J Acquir Immune Defic Syndr (2006) 1.36

HIV-1 transmission in the male genital tract. Am J Reprod Immunol (2010) 1.35

Estimation of influenza vaccine effectiveness from routine surveillance data. PLoS One (2009) 1.32

Adherence to antiretroviral therapy and HIV transmission risks: implications for test-and-treat approaches to HIV prevention. AIDS Patient Care STDS (2010) 1.29

Within 1 h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol (2010) 1.17

HPV and circumcision: a biased, inaccurate and misleading meta-analysis. J Infect (2007) 1.15

[Male circumcision is an effective "surgical vaccine" for HIV prevention and reproductive health]. Zhonghua Nan Ke Xue (2009) 1.14

Polymerase chain reaction detection of Y-chromosome sequences in vaginal fluid of women accessing a sexually transmitted disease clinic. Sex Transm Dis (2006) 1.13

Circumcision in men and the prevention of HIV infection: a 'meta-analysis' revisited. Int J STD AIDS (2000) 1.08

Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men. Int J Cancer (2011) 1.07

Incidence of neonatal circumcision in Atlanta, 1985-1986. South Med J (1995) 1.04

Circumcision and HIV infection: assessment of causality. AIDS Behav (2008) 1.03

Sexual health among male college students in the United States and the Netherlands. Am J Health Behav (2005) 1.02

Male circumcision, human papillomavirus and cervical cancer: from evidence to intervention. J Fam Plann Reprod Health Care (2009) 1.01

The role of male circumcision in the prevention of human papillomavirus and HIV infection. J Infect Dis (2009) 1.00

Declining rates in male circumcision amidst increasing evidence of its public health benefit. PLoS One (2007) 0.99

Attitudes about condoms and condom use among college students. J Am Coll Health (1996) 0.98

HIV infection and circumcision: cutting through the hyperbole. J R Soc Promot Health (2005) 0.92

Male circumcision and HIV infection. Lancet (2000) 0.84

Langerhans cells lap up HIV-1. Nat Med (2007) 0.82

Analysis of the scientific literature on male circumcision and risk for HIV infection. Int J STD AIDS (1999) 0.82

Synthesizing medical evidence: systematic reviews and metaanalyses. Neurosurg Focus (2005) 0.81

Response to Ronald Gray, Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda ( 2000, 14:2371-2381). AIDS (2002) 0.81

Prevalence of Chlamydia trachomatis infection among 'high risk' young people in New South Wales. Sex Health (2006) 0.80

Keratinization of the adult male foreskin and implications for male circumcision. AIDS (2010) 0.80

Assessment of the protective effect of male circumcision from HIV infection and sexually transmitted diseases: evidence from 18 demographic and health surveys in sub-Saharan Africa. Afr J Reprod Health (2010) 0.80

The future of HIV/AIDS in Africa: a shared responsibility. Lancet (2010) 0.79

Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens. Clin Chem Lab Med (2007) 0.78

Errors in meta-analysis by Van Howe. Int J STD AIDS (2009) 0.78

Re: 'RS Van Howe, FM Hodges. The carcinogenicity of smegma: debunking a myth.' An example of myth and mythchief making? J Eur Acad Dermatol Venereol (2008) 0.77

'How to contain generalized HIV epidemics' article misconstrues the evidence. Int J STD AIDS (2011) 0.77

AIDS risk reduction strategies among United States and Swedish heterosexual university students. Arch Sex Behav (1998) 0.76

How does Europe do it? Fam Life Matters (1999) 0.76

Articles by these authors

Scientific evidence dispels false claims about circumcision. Can Urol Assoc J (2014) 0.77